Abstract
Bone healing and graft incorporation is a complex process that involves molecular, cellular, local, and mechanical factors. The interaction of these processes coordinate to allow successful fracture healing and bone formation. Our understanding of bone formation comes from studying the developmental process of bone formation during embryogenesis that mirrors during adult fracture healing. The cellular events of bone formation in combination with biomechanical stability are applied daily to successfully treat patients with various ailments. Several advances in biomedical devices and biologics have improved success rates, allowing surgeons to treat those patients with more options. Before the surgeon can appropriately select the methods and materials with which to treat their patients, they must clearly understand the biological processes that take place normally during bone formation and healing. Without this knowledge and understanding, the surgeon may not achieve optimal success rates in spinal fusions and also increased complications. In this chapter, we reviewed the available biologic options and bone morphogenetic proteins with reference to clinical application in spine surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ahn J, Jorgensen AY, Bohl DD, Tabaraee E, Rossi VJ, Aboushaala K, Singh K (2015). Neuroforaminal bone growth following minimally invasive transforaminal lumbar interbody fusion with BMP: a computed tomographic analysis. J Spinal Disord Tech. Doi: 10.1097/BSD.0000000000000347
Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA (1996) Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res:300–309
Bae HW, Zhao L, Kanim LE, Wong P, Delamarter RB, Dawson EG (2006) Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products, Spine (Phila Pa 1976) 31:1299–1306; discussion 307–8
Bae H, Zhao L, Zhu D, Kanim LE, Wang JC, Delamarter RB (2010) Variability across ten production lots of a single demineralized bone matrix product. J Bone Joint Surg Am 92:427–435
Banwart JC, Asher MA, Hassanein RS (1995) Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine (Phila Pa 1976) 20:1055–1060
Barnes B, Boden SD, Louis-Ugbo J, Tomak PR, Park JS, Park MS, Minamide A (2005) Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine (Phila Pa 1976) 30:1127–1133
Betz RR, Petrizzo AM, Kerner PJ, Falatyn SP, Clements DH, Huss GK (2006) Allograft versus no graft with a posterior multisegmented hook system for the treatment of idiopathic scoliosis. Spine (Phila Pa 1976) 31:121–127
Boden SD, Kang J, Sandhu H, Heller JG (2002) Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) 27:2662–2673
Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS (1998) Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 11:95–101
Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA (1999) Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine (Phila Pa 1976) 24:1179–1185
Boden SD, Schimandle JH, Hutton WC (1995) An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine (Phila Pa 1976) 20:412–420
Bridwell KH, Lenke LG, McEnery KW, Baldus C, Blanke K (1995) Anterior fresh frozen structural allografts in the thoracic and lumbar spine. Do they work if combined with posterior fusion and instrumentation in adult patients with kyphosis or anterior column defects? Spine (Phila Pa 1976) 20:1410–1418
Brown KM, Saunders MM, Kirsch T, Donahue HJ, Reid JS (2004) 'Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg Am 86-a:116–123
Burkus JK, Gornet MF, Dickman CA, Zdeblick TA (2002) Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15:337–349
Cammisa FP Jr, Lowery G, Garfin SR, Geisler FH, Klara PM, McGuire RA, Sassard WR, Stubbs H, Block JE (2004) Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine (Phila Pa 1976) 29:660–666
Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B (2013) Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am 95:1537–1545
Carreon LY, Glassman SD, Anekstein Y, Puno RM (2005) Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine (Phila Pa 1976) 30:E243–E246 ; discussion E47
Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT (2010) Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. J Neurosurg Spine 12:40–46
Comer GC, Smith MW, Hurwitz EL, Mitsunaga KA, Kessler R, Carragee EJ (2012) Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study. Spine J 12:881–890
Connolly JF (1998) Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin Orthop Relat Res:S257–S266
Connolly JF, Shindell R (1986) Percutaneous marrow injection for an ununited tibia. Nebr Med J 71:105–107
Cook SD, Dalton JE, Tan EH, Whitecloud TS 3rd, Rueger DC (1994) In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine (Phila Pa 1976) 19:1655–1663
Cunningham BW, Shimamoto N, Sefter JC, Dmitriev AE, Orbegoso CM, McCarthy EF, Fedder IL, McAfee PC (2002) Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction. Spine J 2:11–24
Dodd CA, Fergusson CM, Freedman L, Houghton GR, Thomas D (1988) Allograft versus autograft bone in scoliosis surgery. J Bone Joint Surg Br 70:431–434
Frechette JP, Martineau I, Gagnon G (2005) Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84:434–439
Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A(Suppl 1):S151–S158
Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA (2003) Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 21:670–675
Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR (2007) Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J 7:44–49
Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, Johnson JR (2005) Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine (Phila Pa 1976) 30:1694–1698
Gupta MC, Theerajunyaporn T, Maitra S, Schmidt MB, Holy CE, Kadiyala S, Bruder SP (2007) Efficacy of mesenchymal stem cell enriched grafts in an ovine posterolateral lumbar spine model. Spine (Phila Pa 1976) 32:720–726 ; discussion 27
Harrison WJ, Lewis CP, Lavy CB (2004) Open fractures of the tibia in HIV positive patients: a prospective controlled single-blind study. Injury 35:852–856
Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM, Shirkhoda A (1999) The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine (Phila Pa 1976) 24:629–636
Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME, Patel R (2000) Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 82:161–173
Jones KB, Maiers-Yelden KA, Marsh JL, Zimmerman MB, Estin M, Saltzman CL (2005) Ankle fractures in patients with diabetes mellitus. J Bone Joint Surg Br 87:489–495
Kanayama M, Hashimoto T, Shigenobu K, Yamane S, Bauer TW, Togawa D (2006) A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine (Phila Pa 1976) 31:1067–1074
Khanna G, Lewonowski K, Wood KB (2006) Initial results of anterior interbody fusion achieved with a less invasive bone harvesting technique. Spine (Phila Pa 1976) 31:111–114
Kim HJ, Buchowski JM, Zebala LP, Dickson DD, Koester L, Bridwell KH (2013) RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up. Spine (Phila Pa 1976) 38:1209–1215
Kim YJ, Bridwell KH, Lenke LG, Rhim S, Cheh G (2006) Pseudarthrosis in long adult spinal deformity instrumentation and fusion to the sacrum: prevalence and risk factor analysis of 144 cases. Spine (Phila Pa 1976) 31:2329–2336
Knapp DR Jr, Jones ET, Blanco JS, Flynn JC, Price CT (2005) Allograft bone in spinal fusion for adolescent idiopathic scoliosis. J Spinal Disord Tech 18(Suppl):S73–S76
Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC (2005) Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine (Phila Pa 1976) 30:1001–1007 ; discussion 07
Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI (1995) A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 219:211–222
Lewandrowski KU, Nanson C, Calderon R (2007) Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J 7:609–614
Maeda T, Buchowski JM, Kim YJ, Mishiro T, Bridwell KH (2009) Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft. Spine (Phila Pa 1976) 34:2205–2212
Magin MN, Delling G (2001) Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep. Spine (Phila Pa 1976) 26:469–478
Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF (1997) Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15:546–557
Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA (1999) Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12:179–186
McLain RF, Boehm CA, Rufo-Smith C, Muschler GF (2009) Transpedicular aspiration of osteoprogenitor cells from the vertebral body: progenitor cell concentrations affected by serial aspiration. Spine J 9:995–1002
Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T (2001) Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine (Phila Pa 1976) 26:933–939
Pelled G, Sheyn D, Tawackoli W, Jun DS, Koh Y, Su S, Cohn Yakubovich D, Kallai I, Antebi B, Da X, Gazit Z, Bae H, Gazit D (2016) BMP6-Engineered MSCs Induce Vertebral Bone Repair in a Pig Model: a Pilot Study. Stem Cells Int 2016:6530624
Perry AC, Prpa B, Rouse MS, Piper KE, Hanssen AD, Steckelberg JM, Patel R (2003) Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res:95–100
Price CT, Connolly JF, Carantzas AC, Ilyas I (2003) Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 28:793–798
Ransford AO, Morley T, Edgar MA, Webb P, Passuti N, Chopin D, Morin C, Michel F, Garin C, Pries D (1998) Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients. J Bone Joint Surg Br 80:13–18
Rihn JA, Kirkpatrick K, Albert TJ (2010) Graft options in posterolateral and posterior interbody lumbar fusion. Spine (Phila Pa 1976) 35:1629–1639
Samartzis D, Shen FH, Matthews DK, Yoon ST, Goldberg EJ, An HS (2003) Comparison of allograft to autograft in multilevel anterior cervical discectomy and fusion with rigid plate fixation. Spine J 3:451–459
Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamarter RB, Dawson EG (1996) Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine (Phila Pa 1976) 21:2115–2122
Sandhu HS, Kanim LE, Toth JM, Kabo JM, Liu D, Delamarter RB, Dawson EG (1997) Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine (Phila Pa 1976) 22:1171–1180
Sandhu HS, Toth JM, Diwan AD, Seim HB 3rd, Kanim LE, Kabo JM, Turner AS (2002) Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine (Phila Pa 1976) 27:567–575
Sawin PD, Traynelis VC, Menezes AH (1998) A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J Neurosurg 88:255–265
Schnee CL, Freese A, Weil RJ, Marcotte PJ (1997) Analysis of harvest morbidity and radiographic outcome using autograft for anterior cervical fusion. Spine (Phila Pa 1976) 22:2222–2227
Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB (2006) Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 31:542–547
Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG (2006) Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) 31:2813–2819
Suh DY, Boden SD, Louis-Ugbo J, Mayr M, Murakami H, Kim HS, Minamide A, Hutton WC (2002) Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine (Phila Pa 1976) 27:353–360
Taghavi CE, Lee KB, Keorochana G, Tzeng ST, Yoo JH, Wang JC (2010) Bone morphogenetic protein-2 and bone marrow aspirate with allograft as alternatives to autograft in instrumented revision posterolateral lumbar spinal fusion: a minimum two-year follow-up study. Spine (Phila Pa 1976) 35:1144–1150
Thalgott JS, Giuffre JM, Fritts K, Timlin M, Klezl Z (2001) Instrumented posterolateral lumbar fusion using coralline hydroxyapatite with or without demineralized bone matrix, as an adjunct to autologous bone. Spine J 1:131–137
Theiss SM, Boden SD, Hair G, Titus L, Morone MA, Ugbo J (2000) The effect of nicotine on gene expression during spine fusion. Spine (Phila Pa 1976) 25:2588–2594
Tomford WW (1995) Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 77:1742–1754
Urist MR (2009) The classic : a morphogenetic matrix for differentiation of bone tissue. Clin Orthop Relat Res 467:3068–3070
Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, Herkowitz HN, Phillips F, Hilibrand A, Albert TJ, Wetzel T, McCulloch JA (2005) Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine (Phila Pa 1976) 30:2709–2716
Weiner, B. K., and M. Walker. 2003. 'Efficacy of autologous growth factors in lumbar intertransverse fusions', Spine (Phila Pa 1976) 28:1968–1970; discussion 71
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Gupta, S., Mohan, V., Gupta, M.C. (2017). Biology of Spine Fusion and Application of Osteobiologics in Spine Surgery. In: Vukicevic, S., Sampath, K. (eds) Bone Morphogenetic Proteins: Systems Biology Regulators. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-47507-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-47507-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47505-9
Online ISBN: 978-3-319-47507-3
eBook Packages: MedicineMedicine (R0)